Drug List Optimization

Drug List Optimization is a methodological framework within pharmaceutical policy and health economics that systematically refines formulary composition by evaluating clinical efficacy, cost-effectiveness, and therapeutic equivalence to maximize patient outcomes and resource allocation efficiency.

5

Publications

91

Citations

25

Authors

12

Institutions

Publications per year

2017–2026

2

Authors

25

  1. DK
    Douglas K. Martin

    University of Toronto, Canada

    1 publications · 21 citations

    1

    h-index

  2. MD
    Michael D. Murray

    Indiana University – Purdue University Indianapolis, United States

    1 publications · 21 citations

    1

    h-index

  3. DM
    David M. Smith

    University of Greenwich, United Kingdom

    1 publications · 21 citations

    1

    h-index

  4. XM
    Xiangyu Meng

    Wuhan University, China

    1 publications · 13 citations

    1

    h-index

  5. SW
    Shuguang Wang

    Shandong University, China

    1 publications · 13 citations

    1

    h-index

1–5 of 25

Venues

  1. Journal of Clinical Epidemiology

    1 publications · 17 citations

    1

    h-index

  2. Journal of the American Geriatrics Society

    1 publications · 21 citations

    1

    h-index

  3. Bioinformatics

    1 publications · 29 citations

    1

    h-index

  4. PubMed

    Repository · 1 publications · 11 citations

    1

    h-index

  5. Bioscience Reports

    1 publications · 13 citations

    1

    h-index

1–5